We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
News Corp Class A
NWSA
$15.2B
| $8.85M | 0.02% |
680,433
+29,180
| +4% | +$365K |
|
702
Crown Holdings
CCK
$12.9B
| $8.84M | 0.02% |
166,928
+5,602
| +3% | +$299K |
|
703
Southwest Gas
SWX
$6.54B
| $8.79M | 0.02% |
105,966
+3,242
| +3% | +$264K |
|
|
MPT
704
Medical Properties Trust
MPT
$2.81B
| $8.78M | 0.02% |
681,120
+42,554
| +7% | +$544K |
|
705
The GEO Group
GEO
$4.1B
| $8.72M | 0.02% |
282,162
+101,722
| +56% | +$2.92M |
|
706
Bio-Rad Laboratories Class A
BIO
$8.74B
| $8.71M | 0.02% |
43,692
+1,507
| +4% | +$290K |
|
707
Equity Lifestyle Properties
ELS
$12.7B
| $8.7M | 0.02% |
225,808
+14,074
| +7% | +$533K |
|
708
Maximus
MMS
$3.19B
| $8.68M | 0.02% |
139,554
+4,108
| +3% | +$241K |
|
709
Woodward
WWD
$21.2B
| $8.63M | 0.02% |
126,985
+4,451
| +4% | +$308K |
|
710
Wintrust Financial
WTFC
$10.8B
| $8.59M | 0.02% |
124,296
+32,768
| +36% | +$2.35M |
|
711
IPG Photonics
IPGP
$3.6B
| $8.59M | 0.02% |
71,145
+2,235
| +3% | +$253K |
|
712
ScottsMiracle-Gro
SMG
$3.97B
| $8.58M | 0.02% |
91,871
+1,383
| +2% | +$128K |
|
713
CNO Financial Group
CNO
$4.99B
| $8.52M | 0.02% |
415,826
+10,775
| +3% | +$216K |
|
|
HR
714
DELISTED
Healthcare Realty Trust Incorporated
HR
| $8.5M | 0.02% |
261,421
+14,495
| +6% | +$449K |
|
715
Dick's Sporting Goods
DKS
$17.9B
| $8.49M | 0.02% |
174,481
+1,403
| +0.8% | +$71.1K |
|
716
Murphy Oil
MUR
$5.48B
| $8.49M | 0.02% |
296,906
+13,880
| +5% | +$400K |
|
717
iShares Russell 1000 Value ETF
IWD
$81.8B
| $8.48M | 0.02% |
73,793
-23,955
| -25% | -$2.75M |
|
|
TCO
718
DELISTED
Taubman Centers Inc.
TCO
| $8.48M | 0.02% |
128,477
+9,921
| +8% | +$687K |
|
719
Watsco Inc
WSO
$12.8B
| $8.45M | 0.02% |
58,989
+5,019
| +9% | +$751K |
|
|
DNB
720
DELISTED
Dun & Bradstreet
DNB
| $8.42M | 0.02% |
77,993
+6,915
| +10% | +$783K |
|
|
DST
721
DELISTED
DST Systems Inc.
DST
| $8.39M | 0.02% |
136,944
+8,176
| +6% | +$474K |
|
722
Texas Roadhouse
TXRH
$13.7B
| $8.39M | 0.02% |
188,315
+19,169
| +11% | +$862K |
|
723
Curtiss-Wright
CW
$26.5B
| $8.38M | 0.02% |
91,881
+4,553
| +5% | +$440K |
|
724
H&R Block
HRB
$5.61B
| $8.38M | 0.02% |
360,305
+7,091
| +2% | +$159K |
|
725
Hancock Whitney
HWC
$6.14B
| $8.36M | 0.02% |
183,438
+17,419
| +10% | +$795K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.